Literature DB >> 21398610

Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM.

Tâm D Quách1, Nataly Manjarrez-Orduño, Diana G Adlowitz, Lin Silver, Hongmei Yang, Chungwen Wei, Eric C B Milner, Iñaki Sanz.   

Abstract

B cell anergy represents an important mechanism of peripheral immunological tolerance for mature autoreactive B cells that escape central tolerance enforced by receptor editing and clonal deletion. Although well documented in mice, the extent of its participation in human B cell tolerance remains to be fully established. In this study, we characterize the functional behavior of strictly defined human naive B cells separated on the basis of their surface IgM (sIgM) expression levels. We demonstrate that cells with lower sIgM levels (IgM(lo)) are impaired in their ability to flux calcium in response to either anti-IgM or anti-IgD cross-linking and contain a significantly increased frequency of autoreactive cells compared with naive B cells with higher levels of sIgM. Phenotypically, in healthy subjects, IgM(lo) cells are characterized by the absence of activation markers, reduction of costimulatory molecules (CD19 and CD21), and increased levels of inhibitory CD22. Functionally, IgM(lo) cells display significantly weaker proliferation, impaired differentiation, and poor Ab production. In aggregate, the data indicate that hyporesponsiveness to BCR cross-linking associated with sIgM downregulation is present in a much larger fraction of all human naive B cells than previously reported and is likely to reflect a state of anergy induced by chronic autoantigen stimulation. Finally, our results indicate that in systemic lupus erythematosus patients, naive IgM(lo) cells display increased levels of CD95 and decreased levels of CD22, a phenotype consistent with enhanced activation of autoreactive naive B cells in this autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398610      PMCID: PMC3095097          DOI: 10.4049/jimmunol.1001946

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  A cellular calculus for signal integration by T cells.

Authors:  A V Gett; P D Hodgkin
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

2.  CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.

Authors:  Julia Jellusova; Ute Wellmann; Kerstin Amann; Thomas H Winkler; Lars Nitschke
Journal:  J Immunol       Date:  2010-03-03       Impact factor: 5.422

3.  Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40.

Authors:  D E Evans; M W Munks; J M Purkerson; D C Parker
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

4.  Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance.

Authors:  A E Pugh-Bernard; G J Silverman; A J Cappione; M E Villano; D H Ryan; R A Insel; I Sanz
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

5.  Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya.

Authors:  Erwan Piriou; Rhonda Kimmel; Kiprotich Chelimo; Jaap M Middeldorp; Peter Sumba Odada; Robert Ploutz-Snyder; Ann M Moormann; Rosemary Rochford
Journal:  J Med Virol       Date:  2009-06       Impact factor: 2.327

6.  Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance.

Authors:  Andrew J Gross; Julia R Lyandres; Anil K Panigrahi; Eline T Luning Prak; Anthony L DeFranco
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

Review 7.  BAFF: a fundamental survival factor for B cells.

Authors:  Fabienne Mackay; Jeffrey L Browning
Journal:  Nat Rev Immunol       Date:  2002-07       Impact factor: 53.106

8.  Novel human transitional B cell populations revealed by B cell depletion therapy.

Authors:  Arumugam Palanichamy; Jennifer Barnard; Bo Zheng; Teresa Owen; Tam Quach; Chungwen Wei; R John Looney; Iñaki Sanz; Jennifer H Anolik
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo.

Authors:  Bao Hoa Duong; Hua Tian; Takayuki Ota; Gladys Completo; Shoufa Han; José Luis Vela; Miyo Ota; Michael Kubitz; Nicolai Bovin; James C Paulson; James Paulson; David Nemazee
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

10.  B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans.

Authors:  Danielle T Avery; Elissa K Deenick; Cindy S Ma; Santi Suryani; Nicholas Simpson; Gary Y Chew; Tyani D Chan; Umamainthan Palendira; Jacinta Bustamante; Stéphanie Boisson-Dupuis; Sharon Choo; Karl E Bleasel; Jane Peake; Cecile King; Martyn A French; Dan Engelhard; Sami Al-Hajjar; Saleh Al-Muhsen; Klaus Magdorf; Joachim Roesler; Peter D Arkwright; Pravin Hissaria; D Sean Riminton; Melanie Wong; Robert Brink; David A Fulcher; Jean-Laurent Casanova; Matthew C Cook; Stuart G Tangye
Journal:  J Exp Med       Date:  2010-01-04       Impact factor: 14.307

View more
  59 in total

Review 1.  The enigmatic function of IgD: some answers at last.

Authors:  Cindy Gutzeit; Kang Chen; Andrea Cerutti
Journal:  Eur J Immunol       Date:  2018-06-12       Impact factor: 5.532

Review 2.  Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment.

Authors:  Ryan M Young; James D Phelan; Wyndham H Wilson; Louis M Staudt
Journal:  Immunol Rev       Date:  2019-09       Impact factor: 12.988

Review 3.  Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.

Authors:  Patrice Hemon; Yves Renaudineau; Marjolaine Debant; Nelig Le Goux; Sreya Mukherjee; Wesley Brooks; Olivier Mignen
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

4.  Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens.

Authors:  Ryan M Young; Tianyi Wu; Roland Schmitz; Moez Dawood; Wenming Xiao; James D Phelan; Weihong Xu; Laurence Menard; Eric Meffre; Wing-Chung C Chan; Elaine S Jaffe; Randy D Gascoyne; Elías Campo; Andreas Rosenwald; German Ott; Jan Delabie; Lisa M Rimsza; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

5.  Bruton's tyrosine kinase promotes persistence of mature anti-insulin B cells.

Authors:  Rachel H Bonami; Allison M Sullivan; James B Case; Hannah E Steinberg; Kristen L Hoek; Wasif N Khan; Peggy L Kendall
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

Review 6.  Rationale for B cell targeting in SLE.

Authors:  Iñaki Sanz
Journal:  Semin Immunopathol       Date:  2014-04-25       Impact factor: 9.623

Review 7.  Tonic Signals: Why Do Lymphocytes Bother?

Authors:  Darienne R Myers; Julie Zikherman; Jeroen P Roose
Journal:  Trends Immunol       Date:  2017-07-25       Impact factor: 16.687

8.  Cross-Reactive Antigen Expressed by B6 Splenocytes Drives Receptor Editing and Marginal Zone Differentiation of IgG2a-Reactive AM14 Vκ8 B Cells.

Authors:  Kerstin Nündel; Purvi Mande; Stephanie L Moses; Patricia Busto; Jaime L Cullen; Madelyn R Schmidt; Mark J Shlomchik; Robert T Woodland; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2019-09-18       Impact factor: 5.422

Review 9.  Germinal centers and autoimmune disease in humans and mice.

Authors:  Anthony L DeFranco
Journal:  Immunol Cell Biol       Date:  2016-08-26       Impact factor: 5.126

Review 10.  Targeting pathological B cell receptor signalling in lymphoid malignancies.

Authors:  Ryan M Young; Louis M Staudt
Journal:  Nat Rev Drug Discov       Date:  2013-03       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.